Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes
Year: 2015
Type: article
Study design: Case Report
Source: Diabetes Care
DOI: 10.2337/dc15-1331
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1725918626
